<DOC>
	<DOCNO>NCT01297400</DOCNO>
	<brief_summary>The objective study evaluate safety efficacy MEBO treatment subject partial thickness burn .</brief_summary>
	<brief_title>A Clinical Study Efficacy Safety MEBOÂ® Wound Ointment Subjects With Partial Thickness Burns</brief_title>
	<detailed_description>MEBO-BPII-001 single-center , randomize , standard care-controlled pilot study topically apply MEBO subject partial thickness burn expect heal 14 day . Twice daily application MEBO versus standard care evaluate parallel design . Fourteen subject randomize ( 7 subject per treatment arm ) one two treatment group .</detailed_description>
	<mesh_term>Burns</mesh_term>
	<criteria>1 . Male female 18 65 year age . 2 . Capable give informed consent . 3 . Thermal origin burn . 4 . Patients must willing comply treatment application . 5 . Capable understand comply study protocol requirement . 6 . Study target burn area previous surgical excision . 1 . Chemical electrical burn . 2 . Patient concomitant injury head trauma , inhalation injury , bone fracture . 3 . Pregnant breastfeed female . 4 . Known suspected allergy component MEBO . 5 . Suspicion presence active systemic local cancer tumor kind . 6 . Any immune deficiency disorder . 7 . Suspected alcohol drug abuse . 8 . Participation another investigational drug study within 30 day prior treatment start .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>Burns , Partial Thickness Burns</keyword>
</DOC>